Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality

Related Experiment Video

Updated: Jun 21, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Michael R Narkewicz1, Dominic Dell Olio, Saul J Karpen

  • 1Department of Pediatrics, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado Denver School of Medicine and the Pediatric Liver Center, The Children's Hospital, Aurora, CO, USA.

The Journal of Pediatrics
|August 1, 2009
PubMed

Insights

Diagnostic testing for metabolic and autoimmune causes of pediatric acute liver failure (PALF) is infrequent in indeterminate cases. Improving these investigations could enhance diagnosis and treatment for children with PALF.

Area of Science:

  • Pediatric Hepatology
  • Acute Liver Failure Research
  • Diagnostic Testing Strategies

Background:

  • Pediatric acute liver failure (PALF) presents a diagnostic challenge, particularly when the etiology remains indeterminate.
  • Timely and accurate diagnosis is crucial for effective management and treatment of PALF.

Purpose of the Study:

  • To assess the frequency of diagnostic testing for common PALF causes (drugs, metabolic, autoimmune, infections) in indeterminate cases.
  • Identify gaps in current diagnostic practices for indeterminate PALF.

Main Methods:

  • Analysis of the PALF Study Group Database.
  • Retrospective review of diagnostic test utilization for 703 PALF patients, focusing on 329 with indeterminate diagnoses.
  • Categorization of tests by etiology: drug-related, metabolic, autoimmune, and infectious.

Main Results:

  • In indeterminate PALF, drug history was obtained in 99%, but urine toxicology and acetaminophen levels were tested in only 36% and 38% respectively.
  • Metabolic disease testing was absent in 54% of patients.
  • Autoimmune antibody testing (ANA, ASMA, LKM) was performed in 63-73% of patients.
  • Infectious disease testing (HAV, HBV, EBV) was conducted in 68-86% of patients.

Conclusions:

  • Diagnostic workup for metabolic and autoimmune etiologies in indeterminate PALF is currently infrequent.
  • There is a significant opportunity to improve diagnostic yield and subsequent treatment strategies for children with PALF.
Abstract

More Related Videos

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...